Rowland Charles A Jr
SEC-identified person · CIK 1383292 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Generation Bio Co. GBIO | Director | filed 2020 - 2026 |
| Viking Therapeutics, Inc. VKTX | Director | filed 2017 - 2026 |
| Orchard Therapeutics plc ORTX | Director | filed 2020 - 2024 |
| Nabriva Therapeutics plc NBRV | Director | filed 2016 - 2022 |
| Blueprint Medicines Corp BPMC | Director | filed 2015 - 2021 |
| Nabriva Therapeutics Plc NBRV | Director | filed 2017 - 2017 |
| Vitae Pharmaceuticals, Inc VTAE | Director | filed 2014 - 2016 |
| Dnib Unwind, INC. BIND | Director | filed 2014 - 2016 |
| Idenix Pharmaceuticals INC IDIX | Director | filed 2013 - 2014 |
| Viropharma INC VPHM | VP, Chief Financial Officer | filed 2008 - 2014 |
| Endo Pharmaceuticals Holdings INC ENDP | EVP, CFO & Treasurer | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.